These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3474234)

  • 21. [Relationship between the expression of insulin-like growth factor I receptors and apoptosis after preliminary chemotherapy, in child and adolescent osteosarcoma].
    Rytwiński K; Wnuk A; Woźniak W; Rychłowska M
    Med Wieku Rozwoj; 2004; 8(2 Pt 1):267-73. PubMed ID: 15738602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell cycle flow cytometric analysis in the diagnosis and management of colorectal carcinoma.
    Sampedro A; Salas-Bustamante A; López-Artimez M; García-Muñíz JL; Urdiales G
    Anal Quant Cytol Histol; 1999 Aug; 21(4):347-52. PubMed ID: 10560513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical characteristics of osteosarcomas and cell aneuploidy in children and adolescents -- retrospective studies].
    Rytwinski K; Rychlowska M; Wnuk A; Klepacka T; Michalak E
    Med Wieku Rozwoj; 2001; 5(3):273-81. PubMed ID: 12004160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous paired analysis of numerical chromosomal aberrations and DNA content in osteosarcoma.
    Serra M; Tarkkanen M; Baldini N; Scotlandi K; Sarti M; Maurici D; Manara MC; Benini S; Bacchini P; Knuutila S; Picci P
    Mod Pathol; 2001 Jul; 14(7):710-6. PubMed ID: 11455004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of DNA image cytophotometry for osteosarcoma.
    Neuburger M; Xia Y; Herget GW; Huang Y; Adler CP
    Anal Quant Cytol Histol; 1999 Dec; 21(6):461-7. PubMed ID: 10626013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometric studies on the relationship between DNA content and clinicopathologic features of pancreatic cancers.
    Bocsi J; Berczi C; Balázs G; Lapis K
    Anticancer Res; 1998; 18(3A):1839-43. PubMed ID: 9673413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80.
    Salzer-Kuntschik M; Delling G; Beron G; Sigmund R
    J Cancer Res Clin Oncol; 1983; 106 Suppl():21-4. PubMed ID: 6577010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of comparing flow cytometry examination and histopathology in prognosing of osteogenic sarcoma - preliminary report].
    Klepacka T; Rytwinski K; Wnuk A; Michalak E; Wozniak W
    Med Wieku Rozwoj; 2000; 4(3):261-7. PubMed ID: 11093343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular DNA content in human osteosarcoma: aspects on diagnosis and prognosis.
    Kreicbergs A; Broström LA; Cewrien G; Einhorn S
    Cancer; 1982 Dec; 50(11):2476-81. PubMed ID: 6958350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic imbalances revealed by comparative genomic hybridization in osteosarcomas.
    Ozaki T; Schaefer KL; Wai D; Buerger H; Flege S; Lindner N; Kevric M; Diallo R; Bankfalvi A; Brinkschmidt C; Juergens H; Winkelmann W; Dockhorn-Dworniczak B; Bielack SS; Poremba C
    Int J Cancer; 2002 Dec; 102(4):355-65. PubMed ID: 12402305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [P-glycoprotein expression in osteosarcoma].
    Pösl M; Grahl K; Amling M; Werner M; Ritzel H; Stenzel I; Hentz M; Winkler K; Delling G
    Pathologe; 1996 Jan; 17(1):50-5. PubMed ID: 8685096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A flow cytometric DNA analysis of giant cell tumors of bone including two cases with malignant transformation.
    Fukunaga M; Nikaido T; Shimoda T; Ushigome S; Nakamori K
    Cancer; 1992 Oct; 70(7):1886-94. PubMed ID: 1525763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.
    Schulte M; Brecht-Krauss D; Werner M; Hartwig E; Sarkar MR; Keppler P; Kotzerke J; Guhlmann A; Delling G; Reske SN
    J Nucl Med; 1999 Oct; 40(10):1637-43. PubMed ID: 10520703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
    Friedlander ML; Hedley DW; Swanson C; Russell P
    J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
    Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
    Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas.
    Uhl M; Saueressig U; Koehler G; Kontny U; Niemeyer C; Reichardt W; Ilyasof K; Bley T; Langer M
    Pediatr Radiol; 2006 Dec; 36(12):1306-11. PubMed ID: 17031633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of DNA aneuploidy of primary and metastatic spontaneous canine osteosarcomas.
    Fox MH; Armstrong LW; Withrow SJ; Powers BE; LaRue SM; Straw RC; Gillette EL
    Cancer Res; 1990 Oct; 50(19):6176-8. PubMed ID: 2400984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
    J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.